$NMTC
NEUROONE MEDICAL TECHNOLOGIES Corp Stock $nmtc

$nmtc Overview Financials Valuation SEC Filings Company Website

2023 Q3 Form 10-Q Financial Statement

#000121390023067019 Filed on August 14, 2023

Income Statement

Concept	2023 Q3	2023 Q2	2022 Q2
Revenue	$782.5K	$629.9K	$32.05K
YoY Change	-61.09%	1865.45%	-20.07%
Cost Of Revenue	$548.1K	$386.2K	$38.46K
YoY Change	553.7%	904.21%	-37.9%
Gross Profit	$234.4K	$243.7K	-$6.413K
YoY Change	-87.84%	-3899.56%	-70.64%
Gross Profit Margin	29.95%	38.68%	-20.01%
Selling, General & Admin	$1.579M	$1.862M	$1.530M
YoY Change	-16.43%	21.75%	-28.17%
% of Gross Profit	673.68%	764.32%
Research & Development	$1.779M	$1.892M	$1.225M
YoY Change	23.72%	54.36%	35.98%
% of Gross Profit	759.15%	776.27%
Depreciation & Amortization	$59.27K	$51.38K	$25.93K
YoY Change	77.35%	98.16%	75.47%
% of Gross Profit	25.29%	21.09%
Operating Expenses	$3.399M	$3.754M	$2.755M
YoY Change	2.15%	36.26%	-9.09%
Operating Profit	-$3.165M	-$3.510M	-$2.761M
YoY Change	126.02%	27.12%	-9.01%
Interest Expense			$0.00
YoY Change
% of Operating Profit
Other Income/Expense, Net	$29.62K	$41.46K	$1.710K
YoY Change	14.58%	2324.56%	-97.95%
Pretax Income	-$3.135M	-$3.469M	-$2.760M
YoY Change	128.12%	25.69%	-6.5%
Income Tax	$0.00
% Of Pretax Income
Net Earnings	-$3.135M	-$3.469M	-$2.760M
YoY Change	128.12%	25.69%	-6.5%
Net Earnings / Revenue	-400.64%	-550.68%	-8610.96%
Basic Earnings Per Share		-$0.20	-$0.17
Diluted Earnings Per Share	-$0.14	-$0.20	-$0.17
COMMON SHARES
Basic Shares Outstanding	23.92M shares	17.56M shares	16.19M shares
Diluted Shares Outstanding		17.58M shares	16.19M shares

Balance Sheet

Concept	2023 Q3	2023 Q2	2022 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments	$5.322M	$3.083M	$10.18M
YoY Change	-52.23%	-69.71%	13.21%
Cash & Equivalents	$5.322M	$3.083M	$10.18M
Short-Term Investments	$0.00	$0.00
Other Short-Term Assets	$263.8K	$278.8K	$296.6K
YoY Change	-11.09%	-6.0%	57.41%
Inventory	$1.727M	$1.517M	$454.3K
Prepaid Expenses	$263.7K	$278.8K	$296.6K
Receivables
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$7.313M	$4.879M	$10.93M
YoY Change	-39.94%	-55.36%	17.88%
LONG-TERM ASSETS
Property, Plant & Equipment	$525.8K	$586.9K	$315.3K
YoY Change	48.69%	86.16%	-20.69%
Goodwill
YoY Change
Intangibles	$89.58K	$95.16K	$117.5K
YoY Change	-19.94%	-19.0%
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets	$784.4K	$879.4K	$641.7K
YoY Change	21.26%	37.04%	19.43%
TOTAL ASSETS
Total Short-Term Assets	$7.313M	$4.879M	$10.93M
Total Long-Term Assets	$784.4K	$879.4K	$641.7K
Total Assets	$8.097M	$5.758M	$11.57M
YoY Change	-36.85%	-50.24%	17.96%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$685.1K	$958.8K	$325.0K
YoY Change	-26.15%	194.99%	9.65%
Accrued Expenses	$1.108M	$789.1K	$487.2K
YoY Change	54.72%	61.95%	11.54%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$1.793M	$1.748M	$814.5K
YoY Change	-42.15%	114.59%	9.06%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00	$0.00
YoY Change
Other Long-Term Liabilities	$55.28K	$88.92K	$138.0K
YoY Change	-53.76%	-35.55%	-33.34%
Total Long-Term Liabilities	$55.28K	$88.92K	$138.0K
YoY Change	-53.76%	-35.55%	-33.34%
TOTAL LIABILITIES
Total Short-Term Liabilities	$1.793M	$1.748M	$814.5K
Total Long-Term Liabilities	$55.28K	$88.92K	$138.0K
Total Liabilities	$1.848M	$1.837M	$952.5K
YoY Change	-42.58%	92.85%	-0.14%
SHAREHOLDERS EQUITY
Retained Earnings	-$62.69M	-$59.55M	-$49.45M
YoY Change	23.33%	20.42%
Common Stock	$23.93K	$17.86K	$16.20K
YoY Change	47.56%	10.29%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$6.249M	$3.921M	$10.62M
YoY Change
Total Liabilities & Shareholders Equity	$8.097M	$5.758M	$11.57M
YoY Change	-36.85%	-50.24%	17.96%

Cashflow Statement

Concept	2023 Q3	2023 Q2	2022 Q2
OPERATING ACTIVITIES
Net Income	-$3.135M	-$3.469M	-$2.760M
YoY Change	128.12%	25.69%	-6.5%
Depreciation, Depletion And Amortization	$59.27K	$51.38K	$25.93K
YoY Change	77.35%	98.16%	75.47%
Cash From Operating Activities	-$2.907M	-$2.940M	-$2.637M
YoY Change	-385.6%	11.52%	15.17%
INVESTING ACTIVITIES
Capital Expenditures	$54.12K	$139.3K	-$54.23K
YoY Change	-181.76%	-356.85%	81.31%
Acquisitions
YoY Change
Other Investing Activities	$4.080K	$1.000M
YoY Change	-100.14%
Cash From Investing Activities	-$50.04K	$860.7K	-$54.23K
YoY Change	-98.35%	-1687.13%	81.31%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	5.189M	1.561M	0.000
YoY Change			-100.0%
NET CHANGE
Cash From Operating Activities	-2.907M	-2.940M	-2.637M
Cash From Investing Activities	-50.04K	860.7K	-54.23K
Cash From Financing Activities	5.189M	1.561M	0.000
Net Change In Cash	2.232M	-518.7K	-2.691M
YoY Change	-210.62%	-80.72%	17.84%
FREE CASH FLOW
Cash From Operating Activities	-$2.907M	-$2.940M	-$2.637M
Capital Expenditures	$54.12K	$139.3K	-$54.23K
Free Cash Flow	-$2.961M	-$3.080M	-$2.582M
YoY Change	-373.15%	19.25%	14.29%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2021Q4	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices		usd
CY2022Q1	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices		usd
CY2022Q2	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices		usd
	dei	Document Type DocumentType	10-Q
	dei	Document Quarterly Report DocumentQuarterlyReport	true
	dei	Document Period End Date DocumentPeriodEndDate	2023-06-30
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
	dei	Document Transition Report DocumentTransitionReport	false
	dei	Entity File Number EntityFileNumber	001-40439
	dei	Entity Registrant Name EntityRegistrantName	NeuroOne Medical Technologies Corporation
	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	27-0863354
	dei	Entity Address Address Line1 EntityAddressAddressLine1	7599 Anagram Drive
	dei	Entity Address City Or Town EntityAddressCityOrTown	Eden Prairie
	dei	Entity Address State Or Province EntityAddressStateOrProvince	MN
	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	55344
	dei	City Area Code CityAreaCode	952
	dei	Local Phone Number LocalPhoneNumber	426-1383
	dei	Security12b Title Security12bTitle	Common stock, $0.001 par value
	dei	Trading Symbol TradingSymbol	NMTC
	dei	Security Exchange Name SecurityExchangeName	NASDAQ
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
	dei	Entity Small Business EntitySmallBusiness	true
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
	dei	Entity Shell Company EntityShellCompany	false
CY2023Q3	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	23919184	shares
CY2023Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	3083458	usd
CY2022Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	8160329	usd
CY2022Q3	us-gaap	Short Term Investments ShortTermInvestments	2981010	usd
CY2022Q3	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	33237	usd
CY2023Q2	us-gaap	Inventory Net InventoryNet	1516527	usd
CY2022Q3	us-gaap	Inventory Net InventoryNet	704538	usd
CY2023Q2	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	278786	usd
CY2022Q3	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	296649	usd
CY2023Q2	us-gaap	Assets Current AssetsCurrent	4878771	usd
CY2022Q3	us-gaap	Assets Current AssetsCurrent	12175763	usd
CY2023Q2	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	95156	usd
CY2022Q3	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	111892	usd
CY2023Q2	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	197324	usd
CY2022Q3	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	181355	usd
CY2023Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	586873	usd
CY2022Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	353599	usd
CY2023Q2	us-gaap	Assets Assets	5758124	usd
CY2022Q3	us-gaap	Assets Assets	12822609	usd
CY2023Q2	us-gaap	Accounts Payable Current AccountsPayableCurrent	958811	usd
CY2022Q3	us-gaap	Accounts Payable Current AccountsPayableCurrent	927662	usd
CY2023Q2	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	789097	usd
CY2022Q3	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	715839	usd
CY2022Q3	us-gaap	Deferred Revenue DeferredRevenue	1455188	usd
CY2023Q2	us-gaap	Liabilities Current LiabilitiesCurrent	1747908	usd
CY2022Q3	us-gaap	Liabilities Current LiabilitiesCurrent	3098689	usd
CY2023Q2	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	88918	usd
CY2022Q3	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	119556	usd
CY2023Q2	us-gaap	Liabilities Liabilities	1836826	usd
CY2022Q3	us-gaap	Liabilities Liabilities	3218245	usd
CY2023Q2	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2022Q3	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2023Q2	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2022Q3	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2023Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2022Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2023Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000	shares
CY2022Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000	shares
CY2023Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	17862162	shares
CY2023Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	17862162	shares
CY2022Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	16216540	shares
CY2022Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	16216540	shares
CY2023Q2	us-gaap	Common Stock Value CommonStockValue	17862	usd
CY2022Q3	us-gaap	Common Stock Value CommonStockValue	16217	usd
CY2023Q2	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	63454618	usd
CY2022Q3	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	60414959	usd
CY2023Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-59551182	usd
CY2022Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-50826812	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	3921298	usd
CY2022Q3	us-gaap	Stockholders Equity StockholdersEquity	9604364	usd
CY2023Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	5758124	usd
CY2022Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	12822609	usd
CY2023Q2	us-gaap	Revenues Revenues	629906	usd
CY2022Q2	us-gaap	Revenues Revenues	32049	usd
	us-gaap	Revenues Revenues	1210661	usd
	us-gaap	Revenues Revenues	102381	usd
CY2023Q2	us-gaap	Cost Of Revenue CostOfRevenue	386240	usd
CY2022Q2	us-gaap	Cost Of Revenue CostOfRevenue	38462	usd
	us-gaap	Cost Of Revenue CostOfRevenue	947799	usd
	us-gaap	Cost Of Revenue CostOfRevenue	158113	usd
CY2023Q2	us-gaap	Gross Profit GrossProfit	243666	usd
CY2022Q2	us-gaap	Gross Profit GrossProfit	-6413	usd
	us-gaap	Gross Profit GrossProfit	262862	usd
	us-gaap	Gross Profit GrossProfit	-55732	usd
	nmtc	Revenue From Collaboration RevenueFromCollaboration	1455188	usd
	nmtc	Revenue From Collaboration RevenueFromCollaboration	6374	usd
CY2023Q2	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	1862389	usd
CY2022Q2	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	1529670	usd
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	5347234	usd
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	5090018	usd
CY2023Q2	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	1891512	usd
CY2022Q2	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	1225351	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	5161322	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	3491193	usd
CY2023Q2	us-gaap	Operating Expenses OperatingExpenses	3753901	usd
CY2022Q2	us-gaap	Operating Expenses OperatingExpenses	2755021	usd
	us-gaap	Operating Expenses OperatingExpenses	10508556	usd
	us-gaap	Operating Expenses OperatingExpenses	8581211	usd
CY2023Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-3510235	usd
CY2022Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-2761434	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-8790506	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-8630569	usd
CY2023Q2	us-gaap	Other Income OtherIncome	41462	usd
CY2022Q2	us-gaap	Other Income OtherIncome	1707	usd
	us-gaap	Other Income OtherIncome	66136	usd
	us-gaap	Other Income OtherIncome	5300	usd
CY2023Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-3468773	usd
CY2022Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-2759727	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-8724370	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-8625269	usd
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	-3468773	usd
CY2022Q2	us-gaap	Net Income Loss NetIncomeLoss	-2759727	usd
	us-gaap	Net Income Loss NetIncomeLoss	-8724370	usd
	us-gaap	Net Income Loss NetIncomeLoss	-8625269	usd
CY2023Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.2
CY2022Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.17
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.52
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.54
CY2023Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	17578871	shares
CY2022Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	16193442	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	16740546	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	15927734	shares
CY2021Q3	us-gaap	Stockholders Equity StockholdersEquity	6553901	usd
CY2021Q4	nmtc	Issuance Of Warrants In Connections With Convertible Notes Offering IssuanceOfWarrantsInConnectionsWithConvertibleNotesOffering	13350582	usd
CY2021Q4	nmtc	Issuance Cost In Connection With Public Offering IssuanceCostInConnectionWithPublicOffering	1352280	usd
CY2021Q4	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition	203072	usd
CY2021Q4	us-gaap	Net Income Loss NetIncomeLoss	-2807475	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	15947800	usd
CY2022Q1	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition	232716	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-3058067	usd
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	13122449	usd
CY2022Q2	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition	255548	usd
CY2022Q2	us-gaap	Net Income Loss NetIncomeLoss	-2759727	usd
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	10618270	usd
CY2022Q3	us-gaap	Stockholders Equity StockholdersEquity	9604364	usd
CY2022Q4	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition	300181	usd
CY2022Q4	us-gaap	Net Income Loss NetIncomeLoss	-1732769	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	8171776	usd
CY2023Q1	nmtc	Issuance Of Common Stock In Connection With Atthemarket Offering Program IssuanceOfCommonStockInConnectionWithAtthemarketOfferingProgram	928257	usd
CY2023Q1	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	-183359	usd
CY2023Q1	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition	237628	usd
CY2023Q1	us-gaap	Stock Issued During Period Value Other StockIssuedDuringPeriodValueOther	-98650	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-3522828	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	5532824	usd
CY2023Q2	nmtc	Issuance Of Common Stock In Connection With Atthemarket Offering Program IssuanceOfCommonStockInConnectionWithAtthemarketOfferingProgram	1624399	usd
CY2023Q2	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	-51366	usd
CY2023Q2	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition	296402	usd
CY2023Q2	us-gaap	Stock Issued During Period Value Other StockIssuedDuringPeriodValueOther	-12188	usd
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	-3468773	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	3921298	usd
	us-gaap	Net Income Loss NetIncomeLoss	-8724370	usd
	us-gaap	Net Income Loss NetIncomeLoss	-8625269	usd
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	136757	usd
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	85198	usd
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	834211	usd
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	691336	usd
	us-gaap	Accretion Amortization Of Discounts And Premiums Investments AccretionAmortizationOfDiscountsAndPremiumsInvestments	45571	usd
	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	-81567	usd
	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	-80020	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-33237	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-48336	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	811989	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	355998	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-85022	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	145462	usd
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-62808	usd
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-87197	usd
	us-gaap	Increase Decrease In Accrued Liabilities And Other Operating Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities	-1510104	usd
	us-gaap	Increase Decrease In Accrued Liabilities And Other Operating Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities	-228315	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-9984048	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-8537351	usd
	us-gaap	Payments To Acquire Short Term Investments PaymentsToAcquireShortTermInvestments	1473419	usd
	us-gaap	Proceeds From Sale Of Short Term Investments ProceedsFromSaleOfShortTermInvestments	4500000	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	326497	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	209044	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	2700084	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-209044	usd
	nmtc	Proceeds From Issuance Of Common Stock In Connection With Private Placement ProceedsFromIssuanceOfCommonStockInConnectionWithPrivatePlacement	2552656	usd
	nmtc	Proceeds From Issuance Of Common Stock In Connection With Private Placement ProceedsFromIssuanceOfCommonStockInConnectionWithPrivatePlacement	13350582	usd
	nmtc	Deferreds Offering Costs DeferredsOfferingCosts	-234725	usd
	nmtc	Deferreds Offering Costs DeferredsOfferingCosts	-1327300	usd
	nmtc	Share Repurchases For The Payment Of Employee Taxes ShareRepurchasesForThePaymentOfEmployeeTaxes	110838	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	2207093	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	12023282	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-5076871	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	3276887	usd
CY2022Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	8160329	usd
CY2021Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	6901346	usd
CY2023Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	3083458	usd
CY2022Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	10178233	usd
	nmtc	Reclass Of Deferred Offering Costs To Additional Paidin Capital In Connection With Public Offering ReclassOfDeferredOfferingCostsToAdditionalPaidinCapitalInConnectionWithPublicOffering	24980	usd
	nmtc	Operating Lease Right Of Use Asset Obtained In Exchange For Operating Lease OperatingLeaseRightOfUseAssetObtainedInExchangeForOperatingLease	97536	usd
	nmtc	Unpaid Deferred Issuance Costsoffset In Prepaids And Other Assets UnpaidDeferredIssuanceCostsoffsetInPrepaidsAndOtherAssets	67159	usd
	nmtc	Increase Decrease In Accounts Payable And Accrued Liability IncreaseDecreaseInAccountsPayableAndAccruedLiability	26798	usd
CY2023Q2	us-gaap	Retained Earnings Unappropriated RetainedEarningsUnappropriated	59600000	usd
	us-gaap	Use Of Estimates UseOfEstimates	<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Management’s Use of Estimates</i></b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.</p>
CY2022Q3	nmtc	Available For Sale Debt Securities Amortized Costs Basis AvailableForSaleDebtSecuritiesAmortizedCostsBasis	2981010	usd
CY2022Q3	us-gaap	Held To Maturity Securities Accumulated Unrecognized Holding Loss HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingLoss	2870	usd
CY2022Q3	us-gaap	Held To Maturity Securities Fair Value HeldToMaturitySecuritiesFairValue	2978140	usd
CY2023Q2	nmtc	Warrantshares Warrantshares	6407495	shares
	nmtc	Warrantshares Warrantshares	6753444	shares
CY2023Q2	nmtc	Stock Options StockOptions	1708906	shares
	nmtc	Stock Options StockOptions	1245582	shares
CY2023Q2	nmtc	Restricted Stock Unit RestrictedStockUnit	431049	shares
	nmtc	Restricted Stock Unit RestrictedStockUnit	443670	shares
CY2020Q3	nmtc	Royalty Minimum Payments Year One RoyaltyMinimumPaymentsYearOne	50000	usd
CY2021Q3	nmtc	Royalty Minimum Payments Year Two RoyaltyMinimumPaymentsYearTwo	100000	usd
CY2022Q3	nmtc	Royalty Minimum Payments Year Three RoyaltyMinimumPaymentsYearThree	150000	usd
CY2019Q4	us-gaap	Payments For Rent PaymentsForRent	6410	usd
CY2021Q3	nmtc	Lease Space LeaseSpace	1162	sqm
CY2021Q3	nmtc	Lease Rental Expense LeaseRentalExpense	4241	usd
CY2022Q4	us-gaap	Lessee Operating Lease Term Of Contract LesseeOperatingLeaseTermOfContract	P2Y
CY2022Q4	us-gaap	Lease Expiration Date1 LeaseExpirationDate1	2024-12-31
CY2023Q2	nmtc	Rent Expense RentExpense	43053	usd
	nmtc	Rent Expense RentExpense	128580	usd
CY2022Q2	nmtc	Rent Expense RentExpense	42185	usd
CY2022	nmtc	Rent Expense RentExpense	128315	usd
	nmtc	Operating Cash Flows From Operating Leases OperatingCashFlowsFromOperatingLeases	100562	usd
	nmtc	Operating Cash Flows From Operating Leases OperatingCashFlowsFromOperatingLeases	97799	usd
	nmtc	Operating Lease Right Of Use Asset Obtained In Exchange For Operating Lease OperatingLeaseRightOfUseAssetObtainedInExchangeForOperatingLease	97536	usd
CY2023Q2	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	197324	usd
CY2022Q3	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	181355	usd
CY2023Q2	nmtc	Lease Liability LeaseLiability	214482	usd
CY2022Q3	nmtc	Lease Liability LeaseLiability	202895	usd
CY2023Q2	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P1Y8M12D
CY2022Q3	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P2Y4M24D
CY2023Q2	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.078	pure
CY2022Q3	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.069	pure
CY2023Q2	nmtc	Lessee Operating Lease Liability Payments Due Next Rolling Twelve Month LesseeOperatingLeaseLiabilityPaymentsDueNextRollingTwelveMonth	68139	usd
CY2023Q2	nmtc	Lessee Operating Lease Liability Payment Due In Rolling Year Two LesseeOperatingLeaseLiabilityPaymentDueInRollingYearTwo	139969	usd
CY2023Q2	nmtc	Lessee Operating Lease Liability Payment Due In Rolling Year Three LesseeOperatingLeaseLiabilityPaymentDueInRollingYearThree	21227	usd
CY2023Q2	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	229335	usd
CY2023Q2	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	14853	usd
CY2023Q2	us-gaap	Operating Lease Liability OperatingLeaseLiability	214482	usd
CY2023Q2	us-gaap	Short Term Lease Commitment Amount ShortTermLeaseCommitmentAmount	125564	usd
CY2023Q2	us-gaap	Long Term Debt And Capital Lease Obligations LongTermDebtAndCapitalLeaseObligations	88918	usd
CY2023Q2	us-gaap	Other Prepaid Expense Current OtherPrepaidExpenseCurrent	211627	usd
CY2022Q3	us-gaap	Other Prepaid Expense Current OtherPrepaidExpenseCurrent	296649	usd
CY2023Q2	us-gaap	Deferred Offering Costs DeferredOfferingCosts	67159	usd
CY2023Q2	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	278786	usd
CY2022Q3	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	296649	usd
CY2023Q2	us-gaap	Deferred Finance Costs Gross DeferredFinanceCostsGross	67159	usd
CY2023Q2	us-gaap	Inventory Work In Process InventoryWorkInProcess	1323508	usd
CY2022Q3	us-gaap	Inventory Work In Process InventoryWorkInProcess	630570	usd
CY2023Q2	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	193019	usd
CY2022Q3	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	73968	usd
CY2023Q2	us-gaap	Inventory Net InventoryNet	1516527	usd
CY2022Q3	us-gaap	Inventory Net InventoryNet	704538	usd
CY2022Q3	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	111892	usd
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	16736	usd
CY2023Q2	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	95156	usd
CY2023Q2	us-gaap	Cost Of Goods And Services Sold Amortization CostOfGoodsAndServicesSoldAmortization	5578	usd
	us-gaap	Cost Of Goods And Services Sold Amortization CostOfGoodsAndServicesSoldAmortization	16736	usd
CY2022Q2	us-gaap	Cost Of Goods And Services Sold Amortization CostOfGoodsAndServicesSoldAmortization	5578	usd
	us-gaap	Cost Of Goods And Services Sold Amortization CostOfGoodsAndServicesSoldAmortization	16736	usd
CY2023Q2	us-gaap	Furniture And Fixtures Gross FurnitureAndFixturesGross	891356	usd
CY2022Q3	us-gaap	Furniture And Fixtures Gross FurnitureAndFixturesGross	538061	usd
CY2022Q3	us-gaap	Capitalized Computer Software Gross CapitalizedComputerSoftwareGross	1895	usd
CY2023Q2	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	891356	usd
CY2022Q3	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	539956	usd
CY2023Q2	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	304483	usd
CY2022Q3	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	186357	usd
CY2023Q2	us-gaap	Property Plant And Equipment Other Net PropertyPlantAndEquipmentOtherNet	586873	usd
CY2022Q3	us-gaap	Property Plant And Equipment Other Net PropertyPlantAndEquipmentOtherNet	353599	usd
CY2023Q2	us-gaap	Depreciation Depreciation	51380	usd
	us-gaap	Depreciation Depreciation	120021	usd
CY2022Q2	us-gaap	Depreciation Depreciation	25928	usd
	us-gaap	Depreciation Depreciation	68462	usd
CY2023Q2	us-gaap	Accrued Payroll Taxes Current And Noncurrent AccruedPayrollTaxesCurrentAndNoncurrent	582806	usd
CY2022Q3	us-gaap	Accrued Payroll Taxes Current And Noncurrent AccruedPayrollTaxesCurrentAndNoncurrent	521368	usd
CY2023Q2	nmtc	Lease Liability Shortterms LeaseLiabilityShortterms	125564	usd
CY2022Q3	nmtc	Lease Liability Shortterms LeaseLiabilityShortterms	83339	usd
CY2023Q2	nmtc	Royalty Payments RoyaltyPayments	80727	usd
CY2022Q3	nmtc	Royalty Payments RoyaltyPayments	111132	usd
CY2023Q2	us-gaap	Accrued Liabilities Current And Noncurrent AccruedLiabilitiesCurrentAndNoncurrent	789097	usd
CY2022Q3	us-gaap	Accrued Liabilities Current And Noncurrent AccruedLiabilitiesCurrentAndNoncurrent	715839	usd
	nmtc	Intial Fee Payment IntialFeePayment	2000000	usd
CY2022Q3	nmtc	Milestone Payments Paid MilestonePaymentsPaid	3500000	usd
	us-gaap	Warrant Exercise Price Increase WarrantExercisePriceIncrease	3
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum	0.029	pure
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.535	pure
	nmtc	Expected Term ExpectedTerm	P5Y
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0	pure
	us-gaap	Related Party Transaction Amounts Of Transaction RelatedPartyTransactionAmountsOfTransaction	5400000	usd
	nmtc	Initial Exclusivity Fee InitialExclusivityFee	2000000	usd
	nmtc	Milestone Payments MilestonePayments	3500000	usd
	nmtc	Fair Value Of Warrants FairValueOfWarrants	100000	usd
CY2023Q2	us-gaap	Deferred Revenue Revenue Recognized1 DeferredRevenueRevenueRecognized1	0	usd
	us-gaap	Deferred Revenue Revenue Recognized1 DeferredRevenueRevenueRecognized1	1455188	usd
CY2022Q2	us-gaap	Deferred Revenue Revenue Recognized1 DeferredRevenueRevenueRecognized1	0	usd
	us-gaap	Deferred Revenue Revenue Recognized1 DeferredRevenueRevenueRecognized1	6374	usd
CY2022Q3	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	1455188	usd
CY2021Q3	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	8622	usd
	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	-1455188	usd
	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	-6374	usd
CY2022Q2	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	2248	usd
CY2023Q2	nmtc	Product Revenue ProductRevenue	629906	usd
	nmtc	Product Revenue ProductRevenue	1210661	usd
CY2022Q2	nmtc	Product Revenue ProductRevenue	32049	usd
	nmtc	Product Revenue ProductRevenue	102381	usd
CY2023Q2	us-gaap	Advertising Expense AdvertisingExpense	49492	usd
	us-gaap	Advertising Expense AdvertisingExpense	156131	usd
CY2022Q2	us-gaap	Advertising Expense AdvertisingExpense	43479	usd
	us-gaap	Advertising Expense AdvertisingExpense	218011	usd
CY2023Q2	us-gaap	Other Selling General And Administrative Expense OtherSellingGeneralAndAdministrativeExpense	237007	usd
CY2022Q2	us-gaap	Other Selling General And Administrative Expense OtherSellingGeneralAndAdministrativeExpense	211472	usd
	us-gaap	Other Selling General And Administrative Expense OtherSellingGeneralAndAdministrativeExpense	691939	usd
	us-gaap	Other Selling General And Administrative Expense OtherSellingGeneralAndAdministrativeExpense	569347	usd
CY2023Q2	us-gaap	Other Research And Development Expense OtherResearchAndDevelopmentExpense	59395	usd
CY2022Q2	us-gaap	Other Research And Development Expense OtherResearchAndDevelopmentExpense	44076	usd
	us-gaap	Other Research And Development Expense OtherResearchAndDevelopmentExpense	142272	usd
	us-gaap	Other Research And Development Expense OtherResearchAndDevelopmentExpense	121989	usd
CY2023Q2	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	296402	usd
CY2022Q2	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	255548	usd
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	834211	usd
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	691336	usd
CY2023Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	339000	shares
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	88890	shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	469512	shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	150690	shares
	nmtc	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Weighted Average Grants Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantsDateFairValue	0.88
	nmtc	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Weighted Average Grants Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantsDateFairValue	0.76
	nmtc	Total Expenses Of Stock Option TotalExpensesOfStockOption	482276	usd
	nmtc	Total Expenses Of Stock Option TotalExpensesOfStockOption	444891	usd
CY2023Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	1708906	shares
CY2022Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	1239915	shares
CY2023Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Weighted Average Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate	0.581	pure
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Weighted Average Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate	0.535	pure
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Weighted Average Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate	0.574	pure
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Weighted Average Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate	0.535	pure
CY2023Q2	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P6Y1M6D
CY2022Q2	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P5Y3M18D
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P5Y9M18D
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P5Y7M6D
CY2023Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0	pure
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0	pure
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0	pure
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0	pure
CY2023Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.036	pure
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.028	pure
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.037	pure
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.023	pure
	nmtc	Sharebased Compensations Arrangement By Share Based Payment Award Options Vested Number Of Shares SharebasedCompensationsArrangementByShareBasedPaymentAwardOptionsVestedNumberOfShares	282172	shares
	nmtc	Sharebased Compensations Arrangement By Share Based Payment Award Options Vested Number Of Shares SharebasedCompensationsArrangementByShareBasedPaymentAwardOptionsVestedNumberOfShares	265901	shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	521	shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	27668	shares
CY2023Q2	nmtc	Aggregate Shares AggregateShares	249000	shares
	nmtc	Aggregate Shares AggregateShares	310728	shares
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Award Vesting Rights Percentage SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage	0.50	pure
CY2022Q2	nmtc	Aggregate Shares AggregateShares	87720	shares
	nmtc	Aggregate Shares AggregateShares	443670	shares
	nmtc	Total Expense Of Restricted Stock Option TotalExpenseOfRestrictedStockOption	351935	usd
	nmtc	Total Expense Of Restricted Stock Option TotalExpenseOfRestrictedStockOption	246445	usd
CY2021Q4	nmtc	Reserved Share ReservedShare	420350	shares
	nmtc	Shares Outstanding Percentage SharesOutstandingPercentage	0.13	pure
CY2023Q1	nmtc	Option Plan Shares OptionPlanShares	129479	shares
CY2023Q2	us-gaap	Common Stock Capital Shares Reserved For Future Issuance CommonStockCapitalSharesReservedForFutureIssuance	1129125	shares
	us-gaap	Employee Benefits And Share Based Compensation EmployeeBenefitsAndShareBasedCompensation	1745365	usd
	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1 EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1	P2Y
	us-gaap	Concentration Risk Customer ConcentrationRiskCustomer	One
CY2023Q2	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0	pure
CY2022Q2	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0	pure
	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0	pure
	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0	pure
CY2022Q4	nmtc	Aggregate Offering Price AggregateOfferingPrice	14500000	usd
CY2022Q4	nmtc	Fixed Commission Rate FixedCommissionRate	0.03	pure
CY2023Q2	nmtc	Sale Of Stock Number Of Shares Issued SaleOfStockNumberOfSharesIssued	1439677	shares
	nmtc	Gross Proceeds GrossProceeds	2552656	usd
	nmtc	Issuance Costs IssuanceCosts	234725	usd
CY2021Q4	nmtc	Issuance Of Shares IssuanceOfShares	3750000	shares
	nmtc	Purchase Of Additional Shares PurchaseOfAdditionalShares	562500	shares
CY2021Q4	nmtc	Sale Of Stock Number Of Shares Issued SaleOfStockNumberOfSharesIssued	422057	shares
CY2023Q2	nmtc	Warrant Expired WarrantExpired	425370	shares
	nmtc	Warrant Expired WarrantExpired	695848	shares
	nmtc	Employees Compensation Percentage EmployeesCompensationPercentage	1	pure
	nmtc	Deferrals Percentage DeferralsPercentage	1	pure
	nmtc	Contributions Percentage ContributionsPercentage	0.03	pure
	nmtc	Internal Revenue Percentage InternalRevenuePercentage	1	pure
CY2023Q2	nmtc	Contributions Amount ContributionsAmount	0	usd
CY2022Q2	nmtc	Contributions Amount ContributionsAmount	0	usd
	nmtc	Contributions Amount ContributionsAmount	30697	usd
	nmtc	Contributions Amount ContributionsAmount	30697	usd
CY2023Q2	nmtc	Excess Stock Share Issued ExcessStockShareIssued	1439677	shares
	us-gaap	Demutualization By Insurance Entity Securities Issued Gross Cash Proceeds DemutualizationByInsuranceEntitySecuritiesIssuedGrossCashProceeds	2552656	usd
	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	234725	usd
CY2023Q3	nmtc	Aggregate Amount AggregateAmount	2560000	usd
CY2023Q3	nmtc	Issuance Shares IssuanceShares	5250000	shares
CY2023Q3	nmtc	Common Stock Par Value Per Share CommonStockParValuePerShare	0.001
CY2023Q3	us-gaap	Shares Issued Price Per Share SharesIssuedPricePerShare	1
CY2023Q3	nmtc	Additional Shares AdditionalShares	787500	shares
CY2023Q3	nmtc	Net Proceeds From Stock Issuance NetProceedsFromStockIssuance	5214875	usd
CY2023Q2	us-gaap	Short Term Investments ShortTermInvestments		usd
CY2023Q2	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent		usd
CY2023Q2	us-gaap	Deferred Revenue DeferredRevenue		usd
CY2022Q4	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices		usd
CY2023Q1	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices		usd
CY2023Q2	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices		usd
	us-gaap	Accretion Amortization Of Discounts And Premiums Investments AccretionAmortizationOfDiscountsAndPremiumsInvestments		usd
	us-gaap	Payments To Acquire Short Term Investments PaymentsToAcquireShortTermInvestments		usd
	us-gaap	Proceeds From Sale Of Short Term Investments ProceedsFromSaleOfShortTermInvestments		usd
	nmtc	Share Repurchases For The Payment Of Employee Taxes ShareRepurchasesForThePaymentOfEmployeeTaxes		usd
	nmtc	Reclass Of Deferred Offering Costs To Additional Paidin Capital In Connection With Public Offering ReclassOfDeferredOfferingCostsToAdditionalPaidinCapitalInConnectionWithPublicOffering		usd
	nmtc	Operating Lease Right Of Use Asset Obtained In Exchange For Operating Lease OperatingLeaseRightOfUseAssetObtainedInExchangeForOperatingLease		usd
	nmtc	Unpaid Deferred Issuance Costsoffset In Prepaids And Other Assets UnpaidDeferredIssuanceCostsoffsetInPrepaidsAndOtherAssets		usd
	nmtc	Increase Decrease In Accounts Payable And Accrued Liability IncreaseDecreaseInAccountsPayableAndAccruedLiability		usd
CY2022Q3	us-gaap	Held To Maturity Securities Accumulated Unrecognized Holding Gain HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingGain		usd
	nmtc	Operating Lease Right Of Use Asset Obtained In Exchange For Operating Lease OperatingLeaseRightOfUseAssetObtainedInExchangeForOperatingLease		usd
CY2022Q3	us-gaap	Deferred Offering Costs DeferredOfferingCosts		usd
CY2023Q2	us-gaap	Capitalized Computer Software Gross CapitalizedComputerSoftwareGross		usd
CY2023Q2	us-gaap	Deferred Revenue Current DeferredRevenueCurrent		usd
CY2023Q2	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit		usd
CY2022Q2	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit		usd
	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit		usd
	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit		usd
	dei	Amendment Flag AmendmentFlag	false
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--09-30
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q3
	dei	Entity Central Index Key EntityCentralIndexKey	0001500198

Files In Submission

Name	View Source	Status
nmtc-20230630_cal.xml	Edgar Link	unprocessable
0001213900-23-067019-index-headers.html	Edgar Link	pending
0001213900-23-067019-index.html	Edgar Link	pending
0001213900-23-067019.txt	Edgar Link	pending
0001213900-23-067019-xbrl.zip	Edgar Link	pending
f10q0623ex31-1_neuroone.htm	Edgar Link	pending
f10q0623ex31-2_neuroone.htm	Edgar Link	pending
f10q0623ex32-1_neuroone.htm	Edgar Link	pending
f10q0623ex32-2_neuroone.htm	Edgar Link	pending
f10q0623_neuroone.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
nmtc-20230630.xsd	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
nmtc-20230630_def.xml	Edgar Link	unprocessable
nmtc-20230630_lab.xml	Edgar Link	unprocessable
nmtc-20230630_pre.xml	Edgar Link	unprocessable
f10q0623_neuroone_htm.xml	Edgar Link	completed
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$NMTC
NEUROONE MEDICAL TECHNOLOGIES Corp Stock $nmtc

2023 Q3 Form 10-Q Financial Statement

#000121390023067019 Filed on August 14, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$NMTC NEUROONE MEDICAL TECHNOLOGIES Corp Stock $nmtc

2023 Q3 Form 10-Q Financial Statement

#000121390023067019 Filed on August 14, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$NMTC
NEUROONE MEDICAL TECHNOLOGIES Corp Stock $nmtc